Innovations + Investments in Healthcare Summit 2015

Bristol-Myers Squibb

Bristol-Myers SquibbBristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit

Bristol-Myers Squibb RSS Channel

Title Filter      Display #  
# Article Title
1 Lilly, Bristol-Myers Squibb Restructure Erbitux® (cetuximab) Collaboration in North America
2 Bristol-Myers Squibb acquires exclusive license from Novo Nordisk for a discovery research program focused on autoimmune diseases
3 FDA approves Opdivo (nivolumab) for the treatment of patients with previously treated metastatic squamous non-small cell lung cancer
4 Bristol-Myers Squibb reports fourth quarter and full year 2014 financial results
5 Bristol-Myers Squibb and California Institute for Biomedical Research (Calibr) sign worldwide research collaboration
6 Bristol-Myers Squibb Foundation awards nine grants to support care for high-risk patients with hepatitis B and C in China and India
7 Bristol-Myers Squibb and Five Prime Therapeutics announce exclusive clinical collaboration
8 Bristol-Myers Squibb to construct a new large-scale biologics manufacturing facility in Ireland
9 Bristol-Myers Squibb enters into agreement that provides an exclusive option to acquire F-star Alpha Ltd. and its novel HER2-targeted therapy
10 Bristol-Myers Squibb and Pfizer announce charitable donations of more than $1 million to support cardiovascular education
11 Allied Minds and Bristol-Myers Squibb form new enterprise
12 Bristol-Myers Squibb reports second quarter 2014 financial results
13 Bristol-Myers Squibb and Syngene International extend research collaboration
14 Bristol-Myers Squibb ranks first on 2014 Best Corporate Citizens List
15 Five Prime Therapeutics and Bristol-Myers Squibb sign collaboration agreement
16 Bristol-Myers Squibb announces charitable donation of $1 million
17 Bristol-Myers Squibb completes previously announced sale of global diabetes business to AstraZeneca
18 Bristol-Myers Squibb Reports fourth quarter and full year 2013 financial results
19 AstraZeneca and Bristol-Myers Squibb Diabetes Alliance provides $5 million grant for American Diabetes Association's Pathway to Stop Diabetes
20 Bristol-Myers Squibb to sell its global diabetes business
World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]